- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Inactive sham approach avoidance training
Total 2118 results
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
Association Tunisienne de lutte Contre le CancerSanofi; Hoffmann-La RocheUnknownInflammatory Breast CancerTunisia
-
Haukeland University HospitalRecruiting
-
National Institute of Allergy and Infectious Diseases...CompletedTuberculosisHaiti, Kenya, Thailand, Malawi, Zimbabwe
-
UNICANCERCompleted
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Bristol-Myers SquibbEisai Inc.RecruitingNeoplasms, OvarianAustralia, United States, Korea, Republic of, Chile, Belgium, Italy, Spain, Israel, Japan
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research...CompletedMelanoma (Skin)United States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)Completed
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainNot yet recruitingPost-operative PainBelgium
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
Central Hospital, Nancy, FranceCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterTerminatedOvarian CancerUnited States
-
SanofiCompleted
-
Currax PharmaceuticalsRecruiting
-
The Greater Poland Cancer CentreActive, not recruiting
-
Hoffmann-La RocheCompletedSolid TumorUnited States, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, China
-
Hoffmann-La RocheCompleted
-
M.D. Anderson Cancer CenterCompleted
-
University of Tennessee Cancer InstituteGenentech, Inc.; Celgene Corporation; National Comprehensive Cancer NetworkUnknownBreast CancerUnited States
-
Case Comprehensive Cancer CenterCompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
AmgenCompletedPsoriasis | Plaque-type PsoriasisUnited States, Canada
-
Shahid Beheshti University of Medical SciencesCompleted
-
Mohammed M MilhemGenentech, Inc.CompletedSarcoma | Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced Sarcoma | Unresectable SarcomaUnited States
-
Miller Children's & Women's Hospital Long BeachChildren's Hospital of Orange CountyRecruitingSolid TumorUnited States
-
Poznan University of Medical SciencesUniversity at Buffalo; The Greater Poland Cancer CentreActive, not recruitingPopulation Modeling of Anti-infective DrugsPoland
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States, Canada
-
National Institute of Integrative Medicine, AustraliaUnknown
-
Accelerated Community Oncology Research NetworkInterMuneCompleted
-
Dr. Susan Love Research FoundationUnknownBreast CancerUnited States
-
St George Hospital, AustraliaSt George & Sutherland Medical Research FoundationUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPolycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditionsUnited States
-
CelgeneCompleted
-
National University Hospital, SingaporeCompleted
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research FundCompletedPancreatic CancerUnited Kingdom
-
National Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Cambridge University Hospitals NHS Foundation TrustUnknownBreast Cancer | Perioperative/Postoperative Complications | Cardiac ToxicityUnited Kingdom
-
Yale UniversityKyowa Kirin, Inc.Not yet recruitingT Cell LymphomaUnited States
-
Acerta Pharma BVAstraZenecaActive, not recruitingDiffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, Canada, Taiwan, Germany, Korea, Republic of, Brazil, Japan, Russian Federation, Poland, China, Israel, Belgium, Australia, Austria, Czechia, Portugal, Mexico, Turkey, India, Ukraine
-
Columbia UniversityCompletedJuvenile Myelomonocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Seattle Children's HospitalCystic Fibrosis FoundationCompletedCystic Fibrosis | Chronic BronchitisUnited States
-
Mayo ClinicCompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
Phramongkutklao College of Medicine and HospitalSilpakorn UniversityRecruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Janssen-Cilag International NVCompletedHuman Immunodeficiency Virus-type 1 InfectionSouth Africa, Kenya, Thailand, Uganda, Cameroon, Senegal